Article Information
History
- May 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jesse H. Erasmus1,2,
- Amit P. Khandhar2,3,
- Alexandra C. Walls6,
- Emily A. Hemann5,8,
- Megan A. O’Connor1,7,
- Patience Murapa1,
- Jacob Archer1,3,
- Shanna Leventhal4,
- Jim Fuller1,
- Thomas Lewis1,7,
- Kevin E. Draves1,
- Samantha Randall3,
- Kathryn A. Guerriero7,
- Malcolm S. Duthie2,
- Darrick Carter2,3,5,
- Steven G. Reed3,5,
- David W. Hawman4,
- Heinz Feldmann4,
- Michael Gale Jr.5,7,8,
- David Veesler6,
- Peter Berglund2 and
- Deborah Heydenburg Fuller1,5,7,*
- 1Department of Microbiology, University of Washington, Seattle, WA
- 2Host Directed Therapeutics (HDT) Bio Corp, Seattle, WA
- 3PAI Life Sciences, Seattle, WA
- 4Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT
- 5Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
- 6Department of Biochemistry, University of Washington, Seattle, WA
- 7Washington National Primate Research Center, Seattle, WA
- 8Department of Immunology, University of Washington, Seattle, WA
- ↵*Corresponding author: Deborah Heydenburg Fuller, Professor, Department of Microbiology, University of Washington, Seattle, WA, Division Chief, Infectious Diseases and Translational Medicine, Washington National Research Primate Research Center, Seattle, WA, fullerdh{at}uw.edu